Related Experiment Video
Updated: Jun 10, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Adjuvant radiotherapy after radical prostatectomy: evidence and analysis
Ann Raldow1, Daniel A Hamstra, Sung N Kim
1Yale School of Medicine, New Haven, CT, United States.
Cancer Treatment Reviews
|July 30, 2010
Summary
Adjuvant radiotherapy (ART) after prostate cancer surgery may reduce recurrence risk for some patients. This review examines evidence, complications, and technical aspects of ART to improve outcomes and quality of life.
Area of Science:
- Oncology
- Radiation Oncology
- Urology
Background:
- Localized prostate cancer surgery can result in positive margins, increasing recurrence risk.
- Adjuvant radiotherapy (ART) is post-surgical treatment for undetectable PSA, aiming to prevent cancer recurrence.
- Current guidelines for ART use are lacking, with many patients only monitored after prostatectomy.
Purpose of the Study:
- To review evidence supporting adjuvant radiotherapy (ART) in prostate cancer patients post-surgery.
- To analyze complication data associated with ART.
- To discuss technical aspects and cost-effectiveness of ART.
Main Methods:
- Review of evidence from three randomized clinical trials on ART.
- Examination of complication data from ART treatments.
- Discussion of technical considerations including dose escalation and target volume.
Main Results:
- Adjuvant radiotherapy has generally been well-tolerated.
- Technical aspects like dose escalation and target volume optimization are crucial for better outcomes.
- ART may offer higher cure rates and improved quality of life when optimized.
Conclusions:
- Adjuvant radiotherapy is a potential treatment to reduce prostate cancer recurrence after surgery.
- Optimizing ART delivery through dose and volume adjustments can enhance efficacy and minimize side effects.
- Further evaluation of ART's cost-effectiveness is warranted.
